İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

cephalon limited - dopexamine hydrochloride - concentrate for soln for inf - 10 micromol

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - dopexamine hydrochloride 1%;   - solution for injection - 1 % - active: dopexamine hydrochloride 1%   excipient: disodium edetate dihydrate hydrochloric acid water for injection

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - dopexamine hydrochloride - solution for infusion - 10mg/1ml

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

cephalon limited - dopexamine hydrochloride - concentrate for soln for inf - 10

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

ipsen limited - dopexamine hydrochloride - 200 milligram

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

ipsen limited - dopexamine hydrochloride - 50 milligram

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - dopamine hydrochloride - solution for infusion - 40mg/1ml

Tanzanya - İngilizce - Tanzania Medicinces & Medical Devices Authority

msd (pty) limited, south africa - dopexamine - film coated tablet - 100

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - dopamine hydrochloride - solution for infusion - 160mg/1ml

Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

bial - portela cª, s.a. - opicapone - parkinson disease - anti-parkinson drugs - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.